COMPARING ANALYTICAL INSTRUMENTS: WHY PHARMA COMPANIES SHOULD CONSIDER LEASING
Posted on Mar 16, 2022 by Scott Crandall.
Automated, advanced and flexible: These are identifiers we want when considering equipment that will increase overall efficiencies and bottom-line profitability. These attributes, however, also remind us of the ever-changing nature of the industry.
There is an avoidable backdrop of regulatory protocols, nation-by-nation site requirements and technological advances to consider when making investments into new equipment. With change so rapid, leasing should be your primary strategy.
Lease agreements offer flexibility, cost savings and are available on a range of equipment including analytical instruments. Below, our experts review what to look for when leasing Mass Spectrometers and Chromatographs.
Mass Spectrometers
Mass spectrometers identify the molecular composition and molar masses within a sample by selecting and electrifying the distinct particles. Pharmaceutical labs can benefit from these features:
Chromatography Systems
Chromatography systems remove elements from a complex mixture. Drug companies often use this machine to identify product contaminants, particularly toxic chiral compounds, which can be difficult to distinguish from their non-toxic counterparts. Research labs should seek the following:
Leasing with a well-resourced supplier, such as Axelerist, allows you access to the most technologically advanced solutions at a rate that can be integrated into your budget and financial projections. We provide same day quotes, servicing and maintenance, and access to leading instrument manufacturers to laboratories around the world.
Learn more about our simple, cost-effective leasing solutions.